Literature DB >> 15150331

Antigenic and/or phase variation of PorA protein in non-subtypable Neisseria meningitidis strains isolated in Spain.

Belen Alcalá1, Celia Salcedo1, Luisa Arreaza1, Raquel Abad1, Rocio Enríquez1, Laura De La Fuente1, Maria Jose Uría1, Julio A Vázquez1.   

Abstract

The PorA protein is a potential candidate as a vaccine component against meningococcal disease. However, this protein experiences antigenic variation and is subject to phase variations to evade immune selective pressure. In this study, the mechanisms responsible for altered expression of the PorA protein were analysed in 50 non-subtypable strains isolated from patients with meningococcal disease in Spain. The porA gene was amplified from 47 of the 50 strains. The majority of isolates were not recognized by the subtyping panel, as a result of non-synonymous base changes in the variable regions of the porA gene. Two of these strains revealed a premature stop codon before the variable region VR1 of PorA due to a single base-pair substitution at position 109 of the porA coding region. Another two presented a homopolymeric tract of eight adenine residues in the coding region, producing a DNA strand-slippage mechanism and PorA phase variation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15150331     DOI: 10.1099/jmm.0.05517-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  11 in total

1.  Investigation on the effect of immune selection on resistance to bactericidal antibodies to group B meningococci in vitro.

Authors:  George F Santos; Marzia Giuliani; Laura Santini; Jeanette Adu-Bobie; Mariagrazia Pizza; Rino Rappuoli; William Wacknov; John Donnelly
Journal:  Clin Vaccine Immunol       Date:  2009-08-26

2.  Hexa-acylated lipid A is required for host inflammatory response to Neisseria gonorrhoeae in experimental gonorrhea.

Authors:  Xiyou Zhou; Xi Gao; Peter M Broglie; Chahnaz Kebaier; James E Anderson; Natalie Thom; Michael A Apicella; Gregory D Sempowski; Joseph A Duncan
Journal:  Infect Immun       Date:  2013-10-14       Impact factor: 3.441

3.  Sequencing of the porB gene: a step toward a true characterization of Neisseria meningitidis.

Authors:  R Abad; B Alcalá; C Salcedo; R Enríquez; M J Uría; P Diez; J A Vázquez
Journal:  Clin Vaccine Immunol       Date:  2006-10

4.  Protective antibody responses elicited by a meningococcal outer membrane vesicle vaccine with overexpressed genome-derived neisserial antigen 1870.

Authors:  Victor C Hou; Oliver Koeberling; Jo Anne Welsch; Dan M Granoff
Journal:  J Infect Dis       Date:  2005-07-15       Impact factor: 5.226

5.  B:2a:p1.5 meningococcal strains likely arisen from capsular switching event still spreading in Spain.

Authors:  Jesús Castilla; Julio A Vázquez; Celia Salcedo; Manuel García Cenoz; José Javier García Irure; Luis Torroba; Xabier Beristain; Raquel Abad; Aurelio Barricarte
Journal:  J Clin Microbiol       Date:  2008-12-17       Impact factor: 5.948

6.  Effect of mesoporous silica under Neisseria meningitidis transformation process: environmental effects under meningococci transformation.

Authors:  Luciana M Hollanda; Gisele Cg Cury; Rafaella Fc Pereira; Gracielle A Ferreira; Andreza Sousa; Edesia Mb Sousa; Marcelo Lancellotti
Journal:  J Nanobiotechnology       Date:  2011-07-25       Impact factor: 10.435

7.  32-week premature rupture of membranes caused by oropharyngeal microbiota.

Authors:  Alberto Hidalgo-Chicharro; José Gutiérrez-Fernández; Raquel Abad-Torreblanca; José María Navarro-Marí
Journal:  JMM Case Rep       Date:  2017-10-12

8.  Two Cases of Neisseria meningitidis Proctitis in HIV-Positive Men Who Have Sex with Men.

Authors:  José Gutierrez-Fernandez; Verónica Medina; Carmen Hidalgo-Tenorio; Raquel Abad
Journal:  Emerg Infect Dis       Date:  2017-03       Impact factor: 6.883

9.  Phase variation of PorA, a major outer membrane protein, mediates escape of bactericidal antibodies by Neisseria meningitidis.

Authors:  Isfahan Tauseef; Youssif M Ali; Christopher D Bayliss
Journal:  Infect Immun       Date:  2013-02-12       Impact factor: 3.441

10.  Predicted Strain Coverage of a New Meningococcal Multicomponent Vaccine (4CMenB) in Spain: Analysis of the Differences with Other European Countries.

Authors:  Raquel Abad; Verónica Medina; Maria Stella; Giuseppe Boccadifuoco; Maurizio Comanducci; Stefania Bambini; Alessandro Muzzi; Julio A Vázquez
Journal:  PLoS One       Date:  2016-03-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.